Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T21:08:13.765Z.
Calculation as of: 2026-10-06T21:08:13.765Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 371c12db8760855cbd67a4f629ef705ee3b50919edbb0a0fc68f9f6d9159db17
EARNINGS YIELD
N/A
Market Cap
$159.80M
Earnings Yield
N/A
TTM Avg
39.99%
3Y Avg
39.99%
5Y Avg
26.90%
Market Cap
$159.14M
Earnings Yield
N/A
TTM Avg
18.91%
3Y Avg
18.91%
5Y Avg
12.56%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quanterix Corporation (QTRX) | $162.04M | N/A | N/A | N/A | N/A |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.80M | N/A | 39.99% | 39.99% | 26.90% |
| PepGen Inc. (PEPG)vs › | $159.78M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $159.14M | N/A | 18.91% | 18.91% | 12.56% |
| Nkarta, Inc. (NKTX)vs › | $165.27M | N/A | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $165.32M | 2.65% | 4.73% | 4.73% | 1.51% |
| Inogen, Inc. (INGN)vs › | $156.22M | N/A | 1.53% | 2.27% | 1.64% |
| Cue Biopharma, Inc. (CUE)vs › | $168.10M | N/A | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $168.92M | N/A | 15.95% | 15.95% | 15.95% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
